John is a co-founder of the Boston Epigenetics Society and an award-winning sales executive with a demonstrated history of working in biotechnology.
Skilled in:
- Next-generation sequencing
- Epigenetics
- Proteomics
- Lab automation
- Liquid handling
- Capital equipment
- Medical devices
- Robotics
- Analytical chemistry
- Research consumables
biomodal is an omics-based life sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus.
John can guide you through our duet multiomics solution which enables more epigenetic information from a single, low-input DNA library without complex, resource-intensive bioinformatics or harsh chemical treatment.